Sfoglia per Rivista  HEPATOLOGY

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 1 a 20 di 58
Titolo Data di pubblicazione Autore(i) File
4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras protooncogenes 1-gen-2015 Wang, C; Cigliano, A; Jiang, L; Li, X; Fan, B; Pilo, Mg; Liu, Y; Gui, B; Sini, M; Smith, Jw; Dombrowski, F; Calvisi, Diego Francesco; Evert, M; Chen, X.
Aberrant fucosylation sustains the NOTCH and EGFR/NF-kB pathways and has a prognostic value in human intrahepatic cholangiocarcinoma 1-gen-2023 Ament, Cindy E; Steinmann, Sara; Evert, Katja; Pes, Giovanni M; Ribback, Silvia; Gigante, Isabella; Pizzuto, Elena; Banales, Jesus M; Rodrigues, Pedro M; Olaizola, Paula; Wang, Haichuan; Giannelli, Gianluigi; Chen, Xin; Evert, Matthias; Calvisi, Diego F
Accomplices in crime: The diabolical liaison between protein tyrosine phosphatase 1B and ras in hepatocellular carcinoma 1-gen-2016 Calvisi, Diego Francesco
Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53 1-gen-2011 Calvisi, Diego Francesco; Simile, Maria Maddalena; Ladu, S; Frau, M; Evert, M; Tomasi, Ml; Demartis, Maria Ilaria; Daino, L; Seddaiu, Maria Antonietta; Brozzetti, S; Feo, F; Pascale, Rosa Maria
Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin 1-gen-2014 Santantonio, T.; Fasano, M.; Sagnelli, E.; Tundo, P.; Babudieri, S.; Fabris, P.; Toti, M.; Di Perri, G.; Marino, N.; Pizzigallo, E.; Angarano, G.; Pastore, G.; Guastadisegni, A.; Volpe, A.; Stano, F.; Tommasi, D.; Maci, A.; Resta, F.; Loperfido, P.; Esposito, R.; Borghi, V.; Fontana, T.; Francavilla, R.; Mazzola, M.; Pipoli, A.; Stanzione, M.; Amoroso, P.; Lettieri, G.; Messina, V.; Antonucci, G.; Rosati, S.; Giacometti, A.; Costa, C.; De Stefano, C. B.; Cariti, G.; Tositti, G.; Piera Riccardi, M.; Verucchi, G.; Francisci, D.; Petrelli, E.; Stoppini, L.; Raimondo, G.; Squadrito, G.; Caccamo, G.; Antonino, P.; Monica, B.; Lazzarin, A.; Morsica, G.; Mian, P.; Pristerà, R.
AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways. 1-gen-2012 Ho, C; Wang, C; Mattu, S; Destefanis, G; Ladu, S; Delogu, S; Armbruster, J; Fan, L; Lee, Sa; Jiang, L; Dombrowski, F; Evert, M; Chen, X; Calvisi, Diego Francesco
AKT/mTOR activation induces a module of metabolic changes contributing to growth in insulin-induced hepatocarcinogenesis. 1-gen-2012 Evert, M; Calvisi, Diego Francesco; Evert, K; De Murtas, V; Gasparetti, G; Mattu, S; Destefanis, G; Ladu, S; Zimmermann, A; Delogu, S; Thiel, S; Thiele, A; Ribback, S; Dombrowski, F.
Antibody to Hepatitis B Surface Antigen in chronic liver disease 1-gen-1982 Tocco, A; Solinas, Antonio; Diana, Msa; Deplano, A; Massarelli, G; Langer, M; Chiandussi, L.
ASSESSMENT OF VARICEAL PRESSURE WITH AN ENDOSCOPIC BALLOOON: EFFECTS OF PHARMACOLOGICAL THERAPY 1-gen-1998 Deplano, A; Multinu, C; Piredda, A; Rheo, A; Garrucciu, G; Gregu, G; Ogana, G; Branca, B; Azara, V; Tocco, A; Carcassi, A; Solinas, Antonio
Axis inhibition protein 1 (Axin1) Deletion–Induced Hepatocarcinogenesis Requires Intact β-Catenin but Not Notch Cascade in Mice 1-gen-2019 Qiao, Y.; Wang, J.; Karagoz, E.; Liang, B.; Song, X.; Shang, R.; Evert, K.; Xu, M.; Che, L.; Evert, M.; Calvisi, D. F.; Tao, J.; Wang, B.; Monga, S. P.; Chen, X.
Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis 1-gen-2002 Pascale, Rosa Maria; Simile, Maria Maddalena; DE MIGLIO, Maria Rosaria; Muroni, Maria Rosaria; Calvisi, Diego Francesco; Asara, G; Casabona, D; Frau, M; Seddaiu, Maria Antonietta; Feo, F.
Characteristic and prevalence of NS3, NS5A and NS5B resistance associated substitutions in DAA-naive and DAA-failed HCV-3 patients in Italy 1-gen-2017 Di Maio, Vc; Barbaliscia, S; Teti, E; Lenci, I; Aragri, M; Polilli, E; Gianserra, L; Palitti, Vp; Bruzzone, B; Paolucci, S; Coppola, N; Ruggiero, T; Pollicino, T; Niero, F; Micheli, V; Di Biagio, A; Bertoli, A; Sticchi, L; Maida, I; Francioso, S; Foroghi, L; Calvaruso, V; Morisco, F; Lleo, A; Ciancio, A; Maserati, R; Brancaccio, G; Puoti, M; Toniutto, P; Vullo, V; Aghemo, A; Cariti, G; Bonora, S; Babudieri, S; Gubertini, Ga; Rendina, M; Pellicelli, Am; Sangiovanni, V; Ciaccio, A; Taliani, G; Raimondo, G; Craxi, A; Pasquazzi, C; Sarmati, L; Parruti, G; Angelico, M; Andreoni, M; Cento, V; Perno, Cf; Ceccherini-Silberstein, F
Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids 1-gen-2022 Ruiz de Gauna, M.; Biancaniello, F.; Gonzalez-Romero, F.; Rodrigues, P. M.; Lapitz, A.; Gomez-Santos, B.; Olaizola, P.; Di Matteo, S.; Aurrekoetxea, I.; Labiano, I.; Nieva-Zuluaga, A.; Benito-Vicente, A.; Perugorria, M. J.; Apodaka-Biguri, M.; Paiva, N. A.; Saenz de Urturi, D.; Buque, X.; Delgado, I.; Martin, C.; Azkargorta, M.; Elortza, F.; Calvisi, D. F.; Andersen, J. B.; Alvaro, D.; Cardinale, V.; Bujanda, L.; Banales, J.; Aspichueta, P.
Classification and survival prediction of hepatocellular carcinoma by gene expression profiling 1-gen-2004 Lee, Js; Chu, I; Heo, J; Calvisi, Diego Francesco; Sun, Z; Roskams, T; Durnez, A; Demetris, Aj; Thorgeirsson, Ss
Connective tissue growth factor autocriny in human hepatocellular carcinoma: oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activation. 1-gen-2011 Urtasun, R; Latasa, Mu; Demartis, Maria Ilaria; Balzani, S; Goñi, S; Garcia Irigoyen, O; Elizalde, M; Azcona, M; Pascale, Rosa Maria; Feo, F; Bioulac Sage, P; Balabaud, C; Muntané, J; Prieto, J; Berasain, C; Avila, Ma
Course of patients coinfected with HIV and hepatotropic viruses 1-gen-1994 Babudieri, Sergio; Cossu, Pa; Tocco, A; Deplano, A; Tanda, Francesco; Ogana, G; Panichi, G; Solinas, Antonio
Current epidemiological trends and outcome in a large cohort of acute hepatitis C patients 1-gen-2005 Santantonio, T; Ferrari, C; Fabris, P; Ho, Sb; Cariti, G; Massari, M; Babudieri, Sergio; Toti, M; Francavilla, R; Ancarani, F; Antonucci, G; Scotto, G; Di Marco, V; Stroffolini, T.
Cytochrome P450 2A6: A new autoantigen in autoimmune liver disease. 1-gen-1996 Clemente, Maria Grazia; Meloni, A; Obermayerstraub, P.
The dark side of the moon: AKT as a tumor suppressor in the liver? 1-gen-2016 Chen, Xin; Calvisi, Diego Francesco
DECLINE OF PREVALENCE OF RESISTANCE ASSOCIATED SUBSTITUTIONS TO NS3 AND NS5A INHIBITORS AT DAA-FAILURE IN HEPATITIS C VIRUS IN ITALY OVER THE YEARS 2015 TO 2018 1-gen-2019 Rossetti, ; (Rossetti, B; 1 ), Barbara)(; Redi, ; (Redi, D; David)(, 1; 2, ); Maio, Di; VC (Di Maio, ; 3 ), Velia Chiara)(; Aragri, ; (Aragri, M; 3 ), Marianna)(; Paolucci, ; (Paolucci, S; 4 ), Stefania)(; Paglicci, ; (Paglicci, L; Lorenzo)(, 1; ) Masetti, 2; (Masetti, C; 5 ), Chiara)(; Bruzzone, ; (Bruzzone, B; 6 ), Bianca)(; Minichini, ; (Minichini, C; 7 ), Carmine)(; Montagnani, ; (Montagnani, F; Francesca)(, 1; ) Micheli, 2; (Micheli, V; 8 ), Valeria)(; Landonio, ; (Landonio, S; 9 ), Simona)(; Zanelli, ; (Zanelli, G; Giacomo)(, 1; ) Degasperi, 2; (Degasperi, E; Elisabetta)( 10, ); Maserati, ; (Maserati, R; Renato)( 11, ); Maida, ; (Maida, I; Ivana)( 12, ); Callegaro, ; (Callegaro, A; Annapaola)( 13, ); Barbaliscia, ; (Barbaliscia, S; 3 ), Silvia)(; Bertoli, ; (Bertoli, A; 3 ), Ada)(; Paternoster, ; (Paternoster, C; Claudio)( 14, ); Marenco, ; (Marenco, S; Simona)( 15, ); Morisco, ; (Morisco, F; Filomena)( 16, ); Calvaruso, ; (Calvaruso, V; Vincenza)( 17, ); Taliani, ; (Taliani, G; Gloria)( 18, ); Puoti, ; (Puoti, M; Massimo)( 19, ); Cenderello, ; (Cenderello, G; Giovanni)( 20, ); Santis, De; A (De Santis, ; Adriano)( 21, ); Lichtner, ; (Lichtner, M; Miriam)( 22, ); Coppola, ; (Coppola, N; 7 ), Nicola)(; Gulminetti, ; (Gulminetti, R; Roberto)( 11, ); Cento, ; (Cento, V; Valeria)( 23, ); Rendina, ; (Rendina, M; Maria)( 24, ); Teti, ; (Teti, E; Elisabetta)( 25, ); Parruti, ; (Parruti, G; Giustino)( 26, ); Ruggiero, ; (Ruggiero, T; Tina)( 27, ); Ghisetti, ; (Ghisetti, V; Valeria)( 27, ); Pasquazzi, ; (Pasquazzi, C; Caterina)( 28, ); Nicolini, ; (Nicolini, La; Laura Ambra)( 29, ); Vullo, ; (Vullo, V; Vincenzo)( 30, ); Pellicelli, ; (Pellicelli, A; Adriano)( 31, ); Prestileo, ; (Prestileo, T; Tullio)( 32, ); Cozzolongo, ; (Cozzolongo, R; Raffaele)( 33, ); Sangiovanni, ; (Sangiovanni, V; Vincenzo)( 34, ); Biolato, ; (Biolato, M; Marco)( 35, ); Lenci, ; (Lenci, I; 5 ), Ilaria)(; Licata, ; (Licata, A; Anna)( 36, ); Ciaccio, ; (Ciaccio, A; Antonio)( 37, ); Palitti, ; (Palitti, Vp; Valeria Pace)( 38, ); Giorgini, ; (Giorgini, A; Alessia)( 39, ); Cariti, ; (Cariti, G; Giuseppe)( 40, ); Ciancio, ; (Ciancio, A; Alessia)( 41, ); Aghemo, ; (Aghemo, A; Alessio)( 42, ); Borghi, ; (Borghi, V; Vanni)( 43, ); Andreone, ; (Andreone, P; Pietro)( 44, ); Brunetto, ; (Brunetto, Mr; )( 45 ), Maurizia R.; Pollicino, ; (Pollicino, T; Teresa)( 46, ); Santantonio, ; (Santantonio, Ta; Teresa Antonia)( 47, ); Cuomo, ; (Cuomo, N; Nunzia)( 48, ); Caudai, ; (Caudai, C; Cinzia)( 49, ); Babudieri, Sergio; (Babudieri, S; Sergio)( 12, ); Lampertico, ; (Lampertico, P; Pietro)( 10, ); Gaeta, ; (Gaeta, Gb; 7 ), Giovanni Battista)(; Raimondo, ; (Raimondo, G; Giovanni)( 46, ); Andreoni, ; (Andreoni, M; Massimo)( 25, ); Rizzardini, ; (Rizzardini, G; 9 ), Giuliano)(; Angelico, ; (Angelico, M; 5 ), Mario)(; Perno, ; (Perno, Cf; Carlo Federico)( 50, ); Craxi, ; (Craxi, A; Antonio)( 17, ); Zazzi, ; (Zazzi, M; 2 ), Maurizio)(; Silberstein, ; (Silberstein, Fc; Francesca, Ceccherini)
Mostrati risultati da 1 a 20 di 58
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile